Global Clinical Trials Playbook

Capacity and Capability Building

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology
Cover of the book Global Clinical Trials Playbook by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780124158603
Publisher: Elsevier Science Publication: June 12, 2012
Imprint: Academic Press Language: English
Author:
ISBN: 9780124158603
Publisher: Elsevier Science
Publication: June 12, 2012
Imprint: Academic Press
Language: English

Pharmaceuticals companies, biotech companies, and CROs, regardless of size, all face the same challenge of managing costs and operational execution associated with bringing a valuable drugs and devices to market. Because of timeline pressures and cost as well as the growing interest in "neglected diseases" and diseases affecting the emerging nations, clinical trials are increasingly conducted in emerging markets and developing countries where infrastructure, leadership, skilled personnel and a governance are at a premium.

Working with academics, regulatory professionals, safety officers, experts from the pharma industry and CROs, the editors have put together this up-to-date, step-by-step guide book to building and enhancing global clinical trial capacity in emerging markets and developing countries.  This book covers the design, conduct, and tools to build and/or enhance human capacity to execute such trials, appealing to individuals in health ministries, pharmaceutical companies, world health organizations, academia, industry, and non-governmental organizations (NGOs) who are managing global clinical trials. 

  • Gives medical professionals the business tools needed to effectively execute clinical trials throughout the world
  • Provides real world international examples which illustrate the practical translation of principles
  • Includes forms, templates, and additional references for standardization in a number of global scenarios
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Pharmaceuticals companies, biotech companies, and CROs, regardless of size, all face the same challenge of managing costs and operational execution associated with bringing a valuable drugs and devices to market. Because of timeline pressures and cost as well as the growing interest in "neglected diseases" and diseases affecting the emerging nations, clinical trials are increasingly conducted in emerging markets and developing countries where infrastructure, leadership, skilled personnel and a governance are at a premium.

Working with academics, regulatory professionals, safety officers, experts from the pharma industry and CROs, the editors have put together this up-to-date, step-by-step guide book to building and enhancing global clinical trial capacity in emerging markets and developing countries.  This book covers the design, conduct, and tools to build and/or enhance human capacity to execute such trials, appealing to individuals in health ministries, pharmaceutical companies, world health organizations, academia, industry, and non-governmental organizations (NGOs) who are managing global clinical trials. 

More books from Elsevier Science

Cover of the book Risks of Hazardous Wastes by
Cover of the book Vegetable Oil-Based Polymers by
Cover of the book Building a Practical Information Security Program by
Cover of the book Fundamentals of Ecosystem Science by
Cover of the book Product Performance Evaluation using CAD/CAE by
Cover of the book Encyclopedia of Spectroscopy and Spectrometry by
Cover of the book Advances in Imaging and Electron Physics by
Cover of the book Academic Libraries and Toxic Leadership by
Cover of the book Genetics of Epilepsy by
Cover of the book Advances in Sequence Stratigraphy by
Cover of the book Protein Engineering and Design by
Cover of the book The Enzymes by
Cover of the book Principles of Fermentation Technology by
Cover of the book Wireless Public Safety Networks 2 by
Cover of the book Understanding Cancer from a Systems Biology Point of View by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy